Metabolic syndrome does not impact survival in patients treated for coronary artery disease

Area of Science:

• Cardiology
• Metabolic Health
• Clinical Outcomes

Background:

• Metabolic syndrome is a known risk factor for developing coronary artery disease (CAD).
• The impact of metabolic syndrome on survival among patients already diagnosed with CAD requires further investigation.
• Understanding prognostic factors in CAD is crucial for patient management.

Purpose of the Study:

• To evaluate the independent effect of metabolic syndrome on the survival rates of patients with established coronary artery disease.
• To determine if metabolic syndrome influences mortality in CAD patients undergoing various treatment modalities.

Main Methods:

• Survival data were analyzed for 2886 patients with CAD diagnosed via cardiac catheterization (1990-2005).
• Multivariate Cox regression analysis was employed using variables from computerized medical records.
• Separate analyses were conducted for patient cohorts receiving percutaneous coronary intervention plus medication, coronary artery bypass grafting plus medication, or medication alone.

Main Results:

• Age, left ventricular function, serum creatinine, and smoking were identified as significant predictors of mortality.
• Metabolic syndrome did not demonstrate an independent effect on mortality, even when considering diabetic status.
• The presence of metabolic syndrome did not alter survival outcomes in the overall cohort or specific treatment groups.

Conclusions:

• Metabolic syndrome does not appear to independently impact survival in patients with established coronary artery disease.
• Treatment strategies, including revascularization and medical therapy, did not alter the lack of association between metabolic syndrome and survival.
• Further research may explore specific components of metabolic syndrome or alternative pathways in CAD prognosis.